TY - JOUR
T1 - Dimerization of the tat protein from human immunodeficiency virus
T2 - A cysteine-rich peptide mimics the normal metal-linked dimer interface
AU - Frankel, A. D.
AU - Chen, L.
AU - Cotter, R. J.
AU - Pabo, C. O.
PY - 1988
Y1 - 1988
N2 - We have synthesized an 18-amino acid peptide that contains the cysteine-rich region of the tat protein from human immunodeficiency virus. Previous experiments in vitro with the intact tat protein have shown that these cysteines serve as metal ligands, causing tat to form metal-linked dimers. Ultraviolet absorption spectra show that the synthetic peptide (tat21-38) binds two Cd2+ or two Zn2+ ions per peptide monomer, and some changes in the circular dichroism spectra are seen as the metals bind. The peptide-metal complexes are completely resistant to proteolytic digestion, and mass spectrometry demonstrates that this peptide forms metal-linked dimers. The peptide can also combine with the intact tat protein to form metal-linked heterodimers. If these heterodimers are unable to trans-activate viral transcription, tat21-38 could be a lead compound for designing drugs to treat acquired immunodeficiency syndrome.
AB - We have synthesized an 18-amino acid peptide that contains the cysteine-rich region of the tat protein from human immunodeficiency virus. Previous experiments in vitro with the intact tat protein have shown that these cysteines serve as metal ligands, causing tat to form metal-linked dimers. Ultraviolet absorption spectra show that the synthetic peptide (tat21-38) binds two Cd2+ or two Zn2+ ions per peptide monomer, and some changes in the circular dichroism spectra are seen as the metals bind. The peptide-metal complexes are completely resistant to proteolytic digestion, and mass spectrometry demonstrates that this peptide forms metal-linked dimers. The peptide can also combine with the intact tat protein to form metal-linked heterodimers. If these heterodimers are unable to trans-activate viral transcription, tat21-38 could be a lead compound for designing drugs to treat acquired immunodeficiency syndrome.
UR - http://www.scopus.com/inward/record.url?scp=0023681468&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023681468&partnerID=8YFLogxK
U2 - 10.1073/pnas.85.17.6297
DO - 10.1073/pnas.85.17.6297
M3 - Article
C2 - 2842763
AN - SCOPUS:0023681468
SN - 0027-8424
VL - 85
SP - 6297
EP - 6300
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 17
ER -